Medicare Enrolled

Dr. Ananth Sastry, M.D.

Ophthalmology · Cleveland, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
9500 EUCLID AVE, Cleveland, OH 44195
2164442801
In practice since 2014 (12 years)
NPI: 1740693936 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sastry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sastry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sastry

Dr. Ananth Sastry is an ophthalmology specialist in Cleveland, OH, with 12 years of NPI registration. Based on federal Medicare data, Dr. Sastry performed 5,735 Medicare services across 1,626 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sastry received a total of $28,709 from 13 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sastry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 13% volume in OH $28,709 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,735
Medicare services
Top 13% in OH for ophthalmology
1,626
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~478 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
2,820 $29 $126
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
849 $22 $188
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
460 $77 $718
Aflibercept eye injection (Eylea) 432 $698 $3,011
Injection, ranibizumab, 0.1 mg 378 $186 $856
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
212 $47 $350
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
105 $61 $452
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
100 $55 $273
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $75 $429
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
79 $47 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
72 $97 $624
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
43 $98 $477
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $31 $119
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
31 $67 $354
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
24 $76 $567
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$28,709
Total received (2018-2024)
Avg $4,785/year across 6 years
Top 7% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
13
Companies
69
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,595 (75.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,113 (24.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,387
2023
$1,858
2022
$16,429
2020
$118
2019
$1,213
2018
$1,705

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Apellis Pharmaceuticals, Inc.
$4,342
Bausch & Lomb Americas Inc.
$1,601
Dutch Ophthalmic, USA
$935
Alcon Vision LLC
$257
ABBVIE INC.
$137
Alimera Sciences, Inc.
$115
Top 3 companies account for 93.1% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$7,475
ABBVIE INC.
$7,027
Apellis Pharmaceuticals, Inc.
$6,682
Bausch & Lomb Americas Inc.
$2,426
Regeneron Pharmaceuticals, Inc.
$1,259
Alcon Laboratories Inc
$1,213
Dutch Ophthalmic, USA
$1,107
Alimera Sciences, Inc.
$464
Alcon Vision LLC
$322
Alcon Research Ltd
$302
Regeneron Healthcare Solutions, Inc.
$245
Ocular Therapeutix, Inc.
$96
Genentech, Inc.
$91
Top 3 companies account for 73.8% of all-time payments
Associated products mentioned in payments ›
AcrySof · Centurion · Constellation · CyPass · DAILIES · DEXTENZA · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ILUVIEN · LASER PROBES · Lucentis · OZURDEX · Rocklatan · STELLARIS ELITE · Stellaris · Syfovre · VABYSMO · XIIDRA · XIPERE · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (75%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for ophthalmology in OH.

Looking for an ophthalmology specialist in Cleveland?
Compare ophthalmologists in the Cleveland area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sastry is a mixed practice specialist, with above-average Medicare volume (top 13% in OH), with consulting-driven industry engagement in the top 7% of OH peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sastry experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Sastry performed 2,820 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sastry receive payments from pharmaceutical companies?
Yes. Dr. Sastry received a total of $28,709 from 13 companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sastry's costs compare to other ophthalmologists in Cleveland?
Dr. Sastry's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sastry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →